Imaging predictors of treatment response in depression.

Trial Profile

Imaging predictors of treatment response in depression.

Completed
Phase of Trial: Phase IV

Latest Information Update: 29 Jan 2014

At a glance

  • Drugs Escitalopram (Primary)
  • Indications Major depressive disorder
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 26 Feb 2013 Planned End Date changed from 1 Dec 2012 to 1 Jul 2013 as reported by ClinicalTrials.gov.
    • 23 Oct 2012 Planned End Date changed from 1 Aug 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.
    • 29 Nov 2011 Actual patient number is 81 according to ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top